Dihydrolipoic Acid

Dihydrolipoic Acid

SCHEMBL715539

O=C([O-])CCCCC(=S)CC=S.O=C([O-])CCCCC(S)CCS.[Na+].[Na+]

nearest known ligand 0.33

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Dihydrolipoic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CA1 known ✓ P00915 1/20 0.30
NFKB1 P19838 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dihydrolipoic Acid SCHEMBL5227074 0.85 GSTK1 (0.41) NFKB1
Dihydrolipoic Acid SCHEMBL718014 0.84 NFKB1 (0.43) NFKB1CA1
SCHEMBL718013 0.83 CA1 (0.41) NFKB1CA1
Dihydrolipoic Acid SCHEMBL2582100 0.81 NFKB1 (0.39) NFKB1CA1
Dihydrolipoic Acid SCHEMBL5827361 0.81 NFKB1 (0.39) NFKB1CA1
Dihydrolipoic Acid SCHEMBL1659440 0.81 NFKB1 (0.39) NFKB1CA1
Dihydrolipoic Acid SCHEMBL4761909 0.80 NFKB1 (0.38) NFKB1CA1
Dihydrolipoic Acid SCHEMBL4094129 0.79 GSTK1 (0.46) NFKB1
SCHEMBL3276879 0.72 HDAC3 (0.36) NFKB1
SCHEMBL3276632 0.71 HDAC3 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220265536-A1 Depilatory Compositions Comprising Aminoalkylpropanol RECKITT BENCKISER (BRANDS) LIMITED (GB) 2022-08-25 US claimed
EP-3402459-B1 DEPILATORY COMPOSITIONS RECKITT BENCKISER HEALTH LTD (GB) 2020-04-22 EP claimed
US-20190008736-A1 Depilatory Compositions Reckitt Benckiser Health Limited (GB) 2019-01-10 US claimed
EP-3402459-A1 DEPILATORY COMPOSITIONS Reckitt Benckiser (Brands) Limited (GB) 2018-11-21 EP claimed
US-9795558-B2 Depilatory formulations and methods of using same RECKITT & COLMAN (OVERSEAS) LIMITED (GB) 2017-10-24 US claimed
WO-2017122020-A1 DEPILATORY COMPOSITIONS RECKITT BENCKISER (BRANDS) LIMITED (GB) 2017-07-20 WO claimed
US-9573001-B2 Depilatory composition RECKITT & COLMAN (OVERSEAS) LIMITED (GB) 2017-02-21 US claimed
EP-2155808-B1 METHOD FOR TREATING THE SURFACE OF A SUBSTRATE BASED ON SULPHUR POLYMER, INTENDED TO BE COVERED WITH A COATING ESSILOR INT (COMPAGNIE GÉNÉRALE D'OPTIQUE) (FR) 2016-12-14 EP claimed
EP-2575742-B1 IMPROVEMENTS IN OR RELATING TO DEPILATORY COMPOSITIONS RECKITT & COLMAN OVERSEAS (GB) 2016-11-02 EP claimed
US-9110223-B2 Method for treating the surface of a substrate based on sulphur polymer, intended to be covered with a coating ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) 2015-08-18 US claimed
EP-2155808-A1 METHOD FOR TREATING THE SURFACE OF A SUBSTRATE BASED ON SULPHUR POLYMER, INTENDED TO BE COVERED WITH A COATING Essilor International (Compagnie Générale D'Optique) (FR) 2010-02-24 EP claimed
US-20100028392-A1 Personal Care Article RECKITT BENCKISER (UK) LIMITED (GB) 2010-02-04 US claimed
EP-2010128-A1 PERSONAL CARE ARTICLE Reckitt Benckiser Healthcare (UK) Limited (GB) 2009-01-07 EP claimed
US-20090004128-A1 Non-Irritant Rapid-Action Dipilatory Composition PRODUCCIONES INFOVISION (MX) 2009-01-01 US claimed
WO-2008155507-A1 METHOD FOR TREATING THE SURFACE OF A SUBSTRATE BASED ON SULPHUR POLYMER, INTENDED TO BE COVERED WITH A COATING ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) 2008-12-24 WO claimed
US-20080260671-A1 Depilatory Compositions RECKITT BENCKISER (UK) LIMITED (GB) 2008-10-23 US claimed
WO-2007128983-A1 PERSONAL CARE ARTICLE RECKITT BENCKISER (UK) LIMITED (GB) 2007-11-15 WO claimed
EP-1001735-B1 DEPILATORY COMPOSITIONS, METHODS FOR THEIR PREPARATION AND THEIR USE RECKITT BENCKISER FRANCE (FR) 2003-03-19 EP claimed
EP-1001735-A1 DEPILATORY COMPOSITIONS, METHODS FOR THEIR PREPARATION AND THEIR USE Reckitt & Colman France (FR) 2000-05-24 EP claimed
WO-1999002125-A1 DEPILATORY COMPOSITIONS, METHODS FOR THEIR PREPARATION AND THEIR USE RECKITT & COLMAN FRANCE (FR) 1999-01-21 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080260671-A1 Depilatory Compositions TYR, NQO1, COMT CA1 3338/4885NFKB1 1035/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.